亚太药业：拟向特定对象增发募资不超过7亿元

Group 1 - The core point of the article is that Asia-Pacific Pharmaceutical (SZ 002370) announced a stock issuance plan to raise up to 700 million yuan for new drug research and development, with a specific issuance price of 5.11 yuan per share [1] - The stock issuance will involve a maximum of approximately 137 million shares, accounting for 18.37% of the company's total share capital before the issuance, and not exceeding 30% of the total share capital prior to the issuance [1] - As of the report, Asia-Pacific Pharmaceutical's market capitalization is 4.2 billion yuan, with 99.33% of its revenue coming from the pharmaceutical manufacturing sector for the first half of 2025 [1]